Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Simple Moving Average

Sell

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Buy

A

XOMA Corporation (XOMA)

Pharmaceutical Preparations

https://www.xoma.com

XOMA Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

2200 POWELL STREET, SUITE 310
EMERYVILLE, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/06/1986

Market Cap

333,578,250

Shares Outstanding

11,490,000

Weighted SO

11,487,808

Total Employees

N/A

Upcoming Earnings

08/13/2024

Similar Tickers

HOWL --.--%

EWTX --.--%

DBTX --.--%

CELC --.--%

CCCC --.--%

THRD --.--%

PASG --.--%

ACRV --.--%

ELYM --.--%

Beta

0.9260

Last Div

2.1600

Range

13.48-30.36

Chg

0.6800

Avg Vol

22941

Mkt Cap

333578250

Exch

NASDAQ

Country

US

Phone

510 204 7200

DCF Diff

31.8978

DCF

-3.7778

Div Yield

0.0165

P/S

21.8898

EV Multiple

-16.0825

P/FV

3.3185

Div Yield %

1.6491

P/E

-18.2042

PEG

0.1326

Payout

-0.3002

Current Ratio

8.7136

Quick Ratio

8.7136

Cash Ratio

7.7305

DSO

354.0780

DIO

0.0000

Op Cycle

354.0780

DPO

789.4934

CCC

-435.4154

Gross Margin

0.9702

Op Margin

-1.2830

Pretax Margin

-1.1961

Net Margin

-1.1961

Eff Tax Rate

0.4919

ROA

-0.0749

ROE

-0.1934

ROCE

-0.0870

NI/EBT

1.0000

EBT/EBIT

0.9323

EBIT/Rev

-1.2830

Debt Ratio

0.4982

D/E

1.2122

LT Debt/Cap

0.5351

Total Debt/Cap

0.5480

Int Coverage

-27.2298

CF/Debt

-0.0735

Equity Multi

2.4330

Rec Turnover

1.0308

Pay Turnover

0.4623

Inv Turnover

0.0000

FA Turnover

39.4793

Asset Turnover

0.0626

OCF/Share

-0.7650

FCF/Share

-2.0262

Cash/Share

12.4195

OCF/Sales

-0.5845

FCF/OCF

2.6486

CF Coverage

-0.0735

ST Coverage

-1.4514

CapEx Coverage

-0.6066

Div&CapEx Cov

-0.4419

P/BV

3.3185

P/B

3.3185

P/S

21.8898

P/E

-18.2042

P/FCF

-14.1401

P/OCF

-37.2545

P/CF

-37.2545

PEG

0.1326

P/S

21.8898

EV Multiple

-16.0825

P/FV

3.3185

DPS

0.4700

Latest Headlines (EST)

GlobeNewswire Inc. Jun 30, 22:14 $HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Turnstone Biologics Corp. (NASDAQ: TSBX) GlobeNewswire Inc. Jan 02, 07:30 XOMA Announces Stock Repurchase Program of up to $50 Million GlobeNewswire Inc. Dec 20, 07:30 XOMA Declares Quarterly Preferred Stock Dividends GlobeNewswire Inc. Nov 07, 07:30 XOMA Reports Third Quarter 2023 Financial Results and Highlights Upcoming Events Expected to Drive Shareholder Value GlobeNewswire Inc. Oct 31, 07:30 XOMA Earns $5 Million Milestone Upon FDA Acceptance of Day One’s Tovorafenib NDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.00 04/02/2024 11/30/-0001 11/30/-0001 11/30/-0001
a